Thus, these results reveal the hypothalamic–pituitary–bone marrow axis as a novel neuroendocrine pathway that contribute to tumor-induced immunosuppression and suggest that MC5R is a potential new target for cancer immunotherapy. The gene discussed is MC5R; the disease is neoplasm.